Perceptive Advisors - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$52,200,000
+92.3%
630,282
+54.0%
0.34%
-1.2%
Q1 2021$27,143,000
-67.0%
409,341
-61.8%
0.34%
-61.1%
Q4 2020$82,164,000
+4113.5%
1,070,814
+3383.7%
0.88%
+2161.5%
Q4 2019$1,950,000
+125.2%
30,7380.0%0.04%
+69.6%
Q3 2019$866,000
-90.1%
30,738
-90.7%
0.02%
-88.6%
Q2 2019$8,765,000
+44.4%
330,7380.0%0.20%
+17.5%
Q1 2019$6,069,000
+69.4%
330,738
+10.2%
0.17%
+25.7%
Q4 2018$3,582,000
-48.9%
300,000
-17.9%
0.14%
-27.3%
Q3 2018$7,006,000
+41.0%
365,4450.0%0.19%
+43.8%
Q2 2018$4,970,000
+88.6%
365,4450.0%0.13%
+75.7%
Q1 2018$2,635,000
+92.1%
365,445
-56.9%
0.07%
+7.2%
Q2 2017$1,372,000
-12.4%
847,4580.0%0.07%
-22.5%
Q1 2017$1,567,000
+19.3%
847,4580.0%0.09%
-4.3%
Q4 2016$1,313,000
-78.9%
847,4580.0%0.09%
-76.9%
Q3 2016$6,228,000847,4580.40%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders